Cipla signs licensing deal with Lilly to manufacture and commercialise baricitinib in India Read more
Baricitinib in combination with remdesivir reduces recovery time in hospitalised COVID-19 patients: Study Read more
Gilead, AstraZeneca and Pfizer may be winners in race for COVID-19 therapeutics and vaccines: GlobalData Read more